A 48-week phase 2 obesity study demonstrated weight reductions of 22.8% and 24.2% with retatrutide 8 and 12 mg, respectively
Discover the potential of small molecules in this field and their role in revolutionizing treatment options and improving patient outcomes
Azevedo, O., Vilarinho, L., Almeida, F., Ferreira, F., Guardado, J., Ferreira, M., Lourenco, A., Medeiros, R., and Almeida, J
each has a different mechanism of action to achieve the same result
Key features that suggest malignancy include irregular margins, necrosis, perilesional edema, and infiltration into surrounding tissues (Widemann & Italiano, 2018)